SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-08T22:21:15.528393+00:00","dedupe_key":"signal_enriched:news_delta:6827d9fa1e47aeb5","evidence_event_ids":["evt_96ed41219912"],"signal_type":"news_headline_delta","source":"news_rss","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IUFh1U2pjNEx4RVVDZmxGRWQ4NTZRS2NoVGFGa2NqeWNWZmJZd3NQOXAyMk84NlY2aTh6d0d6Y1F6V1d5a1RibFRMYlpNNER2R3BqMTNYNGJXSHozZ0w0?oc=5","as_of":"2026-04-08T22:21:15.528393+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IUFh1U2pjNEx4RVVDZmxGRWQ4NTZRS2NoVGFGa2NqeWNWZmJZd3NQOXAyMk84NlY2aTh6d0d6Y1F6V1d5a1RibFRMYlpNNER2R3BqMTNYNGJXSHozZ0w0?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_ef85d5c1843f3693","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-09T22:16:22.832934+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IUFh1U2pjNEx4RVVDZmxGRWQ4NTZRS2NoVGFGa2NqeWNWZmJZd3NQOXAyMk84NlY2aTh6d0d6Y1F6V1d5a1RibFRMYlpNNER2R3BqMTNYNGJXSHozZ0w0?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"nature.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IUFh1U2pjNEx4RVVDZmxGRWQ4NTZRS2NoVGFGa2NqeWNWZmJZd3NQOXAyMk84NlY2aTh6d0d6Y1F6V1d5a1RibFRMYlpNNER2R3BqMTNYNGJXSHozZ0w0?oc=5","source_event_id":"evt_96ed41219912","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"8e8901b3d4f1c9d0","published_at":"2026-04-08T21:45:00+00:00","publisher_domain":"nature.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.55,"dates_mentioned":[],"entities":[{"asset_class":"pharmaceutical","name":"GLP-1 receptor agonist weight-loss drugs","relevance":"high","symbol":"","type":"drug_class"},{"asset_class":"biotech_target","name":"GLP-1","relevance":"high","symbol":"","type":"biological_target"},{"asset_class":"media","name":"Nature","relevance":"high","symbol":"","type":"publisher"}],"event_type":"research","information_gaps":["The provided text does not include the specific genes/variants identified, effect sizes, or which side effects were predicted.","No details are given on study design (cohort size, ancestry composition, endpoints) or whether predictors are clinically validated for prescribing decisions.","No information is provided on which specific GLP-1 receptor agonists (e.g., semaglutide, liraglutide, tirzepatide) were studied.","Near-term timing for clinical adoption (e.g., guideline changes, trial follow-ups) is not specified in the supplied content."],"key_facts":["A Nature article reports that genetics may explain why responses to GLP-1 weight-loss jabs vary.","The Nature framing indicates genetic predictors relate to both weight-loss outcomes and side effects.","Multiple secondary headlines (BBC, Washington Post, Guardian, Scientific American) summarize the same general implication: treatment effectiveness may depend on genetics."],"numeric_claims":[],"primary_claim":"Genetic factors can help predict both the degree of weight loss and the side-effect profile in patients treated with GLP-1 receptor agonist weight-loss drugs.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Nature reports genetic predictors that may explain variability in weight loss and side effects among people treated with GLP-1 receptor agonist weight-loss drugs. The findings suggest genetics could help identify who benefits most and who may experience more adverse effects.","topics":["genetics","pharmacogenomics","GLP-1 receptor agonists","weight loss","side effects","patient stratification"]},"source":"Nature","source_domain":"nature.com","source_url":"https://www.nature.com","summary":"Genetic predictors of GLP1 receptor agonist weight loss and side effects Nature New light shed on who benefits most from weight-loss jabs BBC If you aren\u2019t losing weight with GLP-1 drugs, this may be one reason why The Washington Post Genetics may help explain why results from weight-loss jabs vary, say scientists The Guardian How well GLP-1 weight loss drugs work may depend on your genetics Scientific American","title":"Genetic predictors of GLP1 receptor agonist weight loss and side effects - Nature","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 8505 in events